Related Experiment Video
Updated: Nov 23, 2025

Assessment of Myofilament Ca2+ Sensitivity Underlying Cardiac Excitation-contraction Coupling
Published on: August 1, 2016
Mechanisms underlying pathological Ca2+ handling in diseases of the heart
Satadru K Lahiri1,2, Yuriana Aguilar-Sanchez1,2, Xander H T Wehrens3,4,5,6,7,8
1Cardiovascular Research Institute, Baylor College of Medicine, One Baylor Plaza, BCM335, Houston, TX, 77030, USA.
Insights
This review covers how calcium (Ca2+) handling affects heart function and rhythm. It explores genetic defects and new therapies like genome editing for heart diseases caused by abnormal calcium signaling.
Area of Science:
- Cardiovascular Physiology
- Molecular Cardiology
- Cellular Signaling
Background:
- Cardiomyocyte contraction is regulated by intracellular calcium (Ca2+) signaling.
- Dysregulation of Ca2+ handling is implicated in various heart diseases.
Purpose of the Study:
- To review the physiological regulation of cardiac Ca2+ handling.
- To discuss the role of Ca2+ channel defects in heart disease.
- To highlight novel insights into protein phosphatases and SPEG in cardiac conditions.
Main Methods:
- Literature review of physiological regulation of Ca2+ handling.
- Analysis of genetic variants and acquired defects in Ca2+ channels.
- Summary of recent findings on protein phosphatase and SPEG roles.
- Overview of current and emerging therapeutic strategies.
Main Results:
- Normal cardiac rhythm and contractility depend on precise Ca2+ regulation.
- Inherited or acquired defects in Ca2+ channels contribute to heart diseases.
- Protein phosphatase subunits and SPEG are implicated in atrial fibrillation, heart failure, and cardiomyopathies.
Conclusions:
- Aberrant intracellular Ca2+ signaling is a key factor in cardiac diseases.
- Current drug therapies and genome editing show promise for treating these conditions.
Abstract:
Cardiomyocyte contraction relies on precisely regulated intracellular Ca2+ signaling through various Ca2+ channels and transporters. In this article, we will review the physiological regulation of Ca2+ handling and its role in maintaining normal cardiac rhythm and contractility. We discuss how inherited variants or acquired defects in Ca2+ channel subunits contribute to the development or progression of diseases of the heart. Moreover, we highlight recent insights into the role of protein phosphatase subunits and striated muscle preferentially expressed protein kinase (SPEG) in atrial fibrillation, heart failure, and cardiomyopathies. Finally, this review summarizes current drug therapies and new advances in genome editing as therapeutic strategies for the cardiac diseases caused by aberrant intracellular Ca2+ signaling.
More Related Videos
11:00Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
Published on: September 18, 2017
10:53Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents
Published on: July 3, 2013
Related Concept Videos
Pathophysiology of Heart Failure
Skeleton and Calcium Homeostasis
Antihypertensive Drugs: Action of Calcium Channel Blockers
Mechanism of Cardiac Arrhythmias
Coronary Artery Disease II: Pathophysiology
Feedback Regulation of Calcium Concentration
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...